Paper · 7203558

Activation of natural killer (NK) cells in vivo with H-2 and non-H-2 alloantigens.

Clark EA and 1 other. Immunogenetics, 1981. Cited by 24 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Activation of natural killer (NK) cells in vivo with H-2 and non-H-2 alloantigens. Papers, record 7203558. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7203558

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Activation of natural killer (NK) cells in vivo with H-2 and non-H-2 alloantigens.; PubMed
Journal: Immunogenetics; PubMed
Year: 1981; PubMed
Publication types: Journal Article, Research Support, U.S. Gov't, P.H.S.; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/7203558/; PubMed
DOI: https://doi.org/10.1007/bf01561666; PubMed
The journal: https://conductscience.org/library/journal-index/0420404; PubMed
Citations, by iCite: 24; iCite
Relative citation ratio, by iCite: 0.69; iCite
Revised in PubMed: 2019-08-30; PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	Kind	ORCID iD
1	Clark EA	E A
2	Holly RD	R D

Source PubMed

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
H-2 Antigens	Major topic
Killer Cells, Natural	Major topic
Animals
Ascitic Fluid
Bone Marrow Cells
Cytotoxicity, Immunologic
Dose-Response Relationship, Immunologic
Isoantigens
Kinetics
Lymph Nodes
Mice
Mice, Inbred A
Mice, Inbred BALB C
Mice, Inbred C3H
Mice, Inbred C57BL
Mice, Inbred CBA
Spleen
Thymus Gland

Source PubMed

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes it	Agency	Country	NIH project	Stated by	Source
CA 26713	NCI NIH HHS	United States	R01CA026713	PubMed and NIH	NIH RePORTER
RR 00166	NCRR NIH HHS	United States	P06RR000166	PubMed and NIH	NIH RePORTER
			P40RR000166	NIH	NIH RePORTER
			P51RR000166	NIH	NIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	367,948	Do natural killer cells engage in regulated reactions against self to ensure homeostasis?	Immunol Rev	1979	https://conductscience.org/library/papers/367948	PubMed
2	6,458,874	Induction of natural killer cell activity and allocytotoxicity in human peripheral blood lymphocytes after mixed lymphocyte culture.	Scand J Immunol	1981	https://conductscience.org/library/papers/6458874	PubMed
3	785,281	Introduction of "natural" killer' cells by BCG.	Nature	1976	https://conductscience.org/library/papers/785281	PubMed
4	452,109	Enhancement of mouse NK cells by interferon.	Transplant Proc	1979	https://conductscience.org/library/papers/452109	PubMed
5	158,052	Cytotoxic Thy 1,2-positive blasts with NK-like target selectivity in murine mixed lymphocyte cultures.	J Immunol	1979	https://conductscience.org/library/papers/158052	PubMed
6	299,753	Requirement for non T-cells in the generation of cytotoxic T lymphocytes (CTL) in vitro. II. Characterization of the active cells in the spleen of nude mice.	J Immunol	1977	https://conductscience.org/library/papers/299753	PubMed
7	650,156	Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.	J Exp Med	1978	https://conductscience.org/library/papers/650156	PubMed
8	367,949	An analysis of the murine NK cell as to structure, function and biological relevance.	Immunol Rev	1979	https://conductscience.org/library/papers/367949	PubMed
9	212,503	Ir-genes in H-2 regulate generation of anti-viral cytotoxic T cells. Mapping to K or D and dominance of unresponsiveness.	J Exp Med	1978	https://conductscience.org/library/papers/212503	PubMed
10	112,037	Interaction between antigen-presenting cells and primed T lymphocytes: an assessment of Ir gene expression in the antigen-presenting cell.	Immunol Rev	1978	https://conductscience.org/library/papers/112037	PubMed

1 to 10 of 50

See all 50 references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMID	Title	Journal	Year	In Papers	Source
19,087,311	Immunological tolerance and tumor rejection in embryo-aggregated chimeric mice - lessons for tumor immunity.	BMC Cancer	2008	https://conductscience.org/library/papers/19087311	PubMed
6,971,254	Mutations in mice that influence natural killer (NK) cell activity.	Immunogenetics	1981	https://conductscience.org/library/papers/6971254	PubMed
6,469,290	A genetic analysis of natural resistance to nonsyngeneic cells: the role of H-2.	Immunogenetics	1984	https://conductscience.org/library/papers/6469290	PubMed
6,185,610	"Anomalous" Thy-1+ killer cells in allogeneic and F1-anti-parental mixed leukocyte culture. Relation to natural killer cells and allospecific cytotoxic T lymphocytes.	J Exp Med	1983	https://conductscience.org/library/papers/6185610	PubMed

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes	Source
HCCS	3,052	PubTator's text mining	https://conductscience.org/library/genes/3052	NCBI Gene
TACR1	6,869	PubTator's text mining	https://conductscience.org/library/genes/6869	NCBI Gene
THY1	7,070	PubTator's text mining	https://conductscience.org/library/genes/7070	NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7203558

GET https://conductscience.org/api/papers/v1/7203558/references?page=2

API reference For AI assistants